Recent Updates

Modified on: 
Apr 30, 2020
  • Alloimmunization is common in patients with sickle cell disease and may complicate transfusion therapy.
  • Patient phenotyping and prophylactic matching to reduce alloimmunization is recommended.
  • Transfusion requirements and the presence or absence of red cell antibodies influence recommendations on the extent of phenotyping for patients with sickle cell disease.
  • Limited evidence exists on the impact of the storage age of blood in this population, but provision of fresh units imposes significant challenges and may compromise availability of optimally phenotype-matched units.
Transfusion
Modified on: 
Apr 21, 2020

Journal Publications 

Organs and Tissues
Modified on: 
Apr 20, 2020

To accompany the 2020 Canadian clinical practice guideline for the medical management of deceased organ donors, Canadian Blood Services has created a knowledge translation tool specific to families and substitute decision makers. 

Medical management of deceased organ donors 

Prise en charge médicale des donneurs d'organes après le décès

Organs and Tissues
Modified on: 
Apr 6, 2020

Evidence bulletins are an attractive, user-friendly, evidence-based knowledge translation tool. Each bulletin is a one-page, letter-size card addressing one specific intervention in the management of deceased donors, highlighting:

Organs and Tissues
Modified on: 
Apr 6, 2020

These order sets for deceased organ donor management are based on the Canadian clinical practice guideline published in 2020. Hospitals, intensive care units, and provincial organ donation organizations may adopt or adapt these as standing orders to optimize organ function during medical management of neurologically deceased organ donors. 

Standing Orders for the Medical Management of Neurologically Deceased Donors - Pediatrics

Organs and Tissues
Modified on: 
Apr 2, 2020

April 1, 2020 - In the evolving COVID-19 pandemic, administrative and medical leads of the organ donation and transplantation community across Canada are meeting regularly to collaboratively develop recommendations that can be used by provincial organ donation organizations and regional transplant and donation programs to guide the administration of organ and tissue donation and transplantation services.

Organs and Tissues
Modified on: 
Mar 30, 2020

Author: Matthew Yan, MD, FRCPC
Publication date: January 2020
Primary target audience: health-care professionals working in hospitals in Canada, excluding Quebec

 

Transfusion
Modified on: 
Mar 27, 2020

ODTEAC provides expert advice on donation and transplantation system activities for ongoing advancement and implementation of national initiatives in partnership with Canadian Blood Services.

Members Organization
CHAIR
Dr. Norman Kneteman

University of Alberta Hospital, Alberta Health Services, Edmonton, Alberta

Organs and Tissues
Modified on: 
Mar 14, 2020

Canadian Blood Services works with the Organ and Tissue Donation and Transplantation (OTDT) community to improve national system performance. We do this through the development of leading practices, professional education, public awareness and data analysis and reporting. We also manage clinical programs that support interprovincial sharing of organs.

Organs and Tissues
Modified on: 
Feb 10, 2020

Data Sets

National OTDT Data Working Groups have been created to establish standardized data sets that will allow alignment of information collected and reported across the country. These reports represent the first step in building a comprehensive national data set for organ and tissue donation and transplantation.

Organs and Tissues

Pages